Minutes of the CVMP meeting 11-13 March 2025

Human medicines European public assessment report (EPAR): Cabometyx, cabozantinib, Date of authorisation: 09/09/2016, Revision: 19, Status: Authorised

Substances considered as not falling within the scope of Regulation (EC) No. 470/2009, with regard to residues of veterinary medicinal products in foodstuffs of animal origin

Assessment of public health risks related to antimicrobial resistance acquired via the environment, resulting from the use of a veterinary medicinal product - Scientific guideline

PSUSA/00002920/202408

Human medicines European public assessment report (EPAR): Zefylti, filgrastim, Date of authorisation: 12/02/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Tamiflu, oseltamivir, Date of authorisation: 20/06/2002, Revision: 43, Status: Authorised

Human medicines European public assessment report (EPAR): Inovelon, rufinamide, Date of authorisation: 16/01/2007, Revision: 25, Status: Authorised

Fees payable to the European Medicines Agency

Fees payable to the European Medicines Agency: Annual fees and remuneration